Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises funds managed by Triton in connection with acquisition
Mandate

Vinge advises funds managed by Triton in connection with acquisition

April 30, 2018 Banking and Finance

Vinge has advised funds managed by Triton in connection with the acquisition of the privately owned company Mark & Energibyggarna i Göteborg AB, a supplementary acquisition to its portfolio company Akeab.

Mark & Energibyggarna is a successful supplier of services within facility construction in the Gothenburg area. Mark & Energibyggarna is connected to KEWAB and Akeab as a new sister company in an infrastructure group, focused on facility and construction work, owned by Triton and the management of the companies in question.

Vinge’s team consisted of partner Christina Kokko together with, among others, associates Oscar Rydén, Johanna Wiberg and Michaela Cronemyr. Partner Albert Wållgren and associates Adelwald and Sara Osman provided financing advice. Partner Marcus Glader and associates Xandra Ståhlberg and Fredrika Hjelmberg provided competition law advice.

Related

Vinge advises Atria Sverige in conjunction with an investment in Cookin Food

 Atria Sverige has acquired a 25 per cent stake in the Swedish convenience food company Cookin Food Sweden AB. The transaction has been performed through the acquisition of shares in Bite Delight AB, which owns Cookin Food Sweden AB. Atria holds an option to acquire the remaining shares in Bite Delight AB after 2028.
March 04, 2026

Vinge advises Revivo Group on the acquisition of Solidenergy

 Revivo Group, a portfolio company of Helix Kapital, has acquired Solidenergy, a leading provider of surface treatment services in the Norwegian market. The company operates within the energy, offshore and infrastructure sectors and is headquartered in Ågotnes outside Bergen. Solidenergy employs approximately 600 people.
March 03, 2026

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a partially guaranteed rights issue which is expected to provide Oncopeptides with proceeds of approximately SEK 200 million before deduction of transaction costs.
March 03, 2026